News
Family in plea for cancer treatment support

Family in plea for cancer treatment support
A Killarney family has launched a fundraising campaign to support vital cancer treatment abroad for Warren Tierney, who is battling stage-four oesophagus cancer.
Warren’s partner, Evelyn Dore, has organised a GoFundMe appeal to help cover the cost of specialised treatment in Germany, which is estimated at around €40,000 per session.
On the fundraising page, Evelyn explained the family’s situation:
“Our fight against cancer. When I was pregnant with both Trinity and Wesley, I was very sick. Through it all, Warren carried us. For the past three years, he has devoted himself entirely to looking after me and our two little ones — pouring every ounce of his strength into our family and never once thinking of himself. In giving so much, Warren forgot to look after his own health. When he began to feel unwell, doctors sent him home with reflux tablets. But deep down, we knew something wasn’t right. We had to fight our way through A&E, begging them to take it seriously. Then came the devastating news: stage 4 adenocarcinoma of the oesophagus.”
This week, the family confirmed they were able to secure a 10% discount on Warren’s first treatment. They travelled to Munich, where he will undergo localised chemotherapy at Medias Klinikum Burghausen. The cost of the first session was €38,557. Evelyn said they are grateful for the support received so far but added that more treatments will be needed.
Donations can be made at:
https://www.gofundme.com/f/help-warren-with-esophagus-cancer?cdn-cache=0
News
Halloween Horror at Outlet Centre
Things are set to get spooky in Killarney this Halloween as the Killarney Outlet Centre hosts its annual Halloween Horror Spooktacular on Sunday, October 26, from 2pm to 6pm. Ghosts, […]
News
Fergal Brosnan appointed CEO of RDI Hub
The RDI Hub in Killorglin has announced the appointment of Fergal Brosnan as its new Chief Executive Officer. Brosnan succeeds Liam Cronin, who becomes Director of Innovation at NovaUCD. A […]